Delcath Systems (DCTH) Given Media Sentiment Rating of 0.14

Media coverage about Delcath Systems (NASDAQ:DCTH) has been trending somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Delcath Systems earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned media headlines about the medical device company an impact score of 45.6019477159148 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Here are some of the news stories that may have impacted Accern’s rankings:

Delcath Systems (NASDAQ:DCTH) traded up 0.2646% on Tuesday, hitting $0.0379. The stock had a trading volume of 944,921 shares. Delcath Systems has a 52-week low of $0.02 and a 52-week high of $3.27. The stock’s 50-day moving average is $0.08 and its 200-day moving average is $0.09. The company’s market cap is $16.09 million.

COPYRIGHT VIOLATION NOTICE: “Delcath Systems (DCTH) Given Media Sentiment Rating of 0.14” was originally reported by BBNS and is the property of of BBNS. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://baseballnewssource.com/markets/delcath-systems-dcth-receiving-somewhat-favorable-media-coverage-accern-reports/1698844.html.

Delcath Systems Company Profile

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Insider Buying and Selling by Quarter for Delcath Systems (NASDAQ:DCTH)

Receive News & Ratings for Delcath Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1


Leave a Reply

 
© 2006-2017 BBNS.